{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-095136","form_type":"8-K","ticker":"VCNX","cik":"0001205922","company_name":"VACCINEX, INC.","filed_at":"2022-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.963959+00:00","generated_at":"2026-06-26T09:42:53.222882+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Vaccinex grants stock options and 7% salary increases to top executives","bullets":["CEO Maurice Zauderer receives options for 28,000 shares at $1.29, vesting over 4 years.","CSO Ernest Smith gets options for 20,000 shares; CFO Scott Royer gets 16,000 shares at same price.","Base salaries raised 7%: Zauderer to $406,600, Smith to $287,981, Royer to $262,223.","Options granted under 2018 Omnibus Incentive Plan, expire 10 years from grant date April 1, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-095136","json":"https://secwatch.observer/filing/0001193125-22-095136.json","markdown":"https://secwatch.observer/filing/0001193125-22-095136.md","text":"https://secwatch.observer/filing/0001193125-22-095136.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1205922/000119312522095136/0001193125-22-095136-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1205922/000119312522095136/d325737d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T09:42:53.222882+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}